Drug General Information
Drug ID
D02EFK
Former ID
DNC013204
Drug Name
N1,2-dibenzyl-N3-hydroxy-N1-phenethylmalonamide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528703]
Structure
Download
2D MOL

3D MOL

Formula
C25H26N2O3
Canonical SMILES
C1=CC=C(C=C1)CCN(CC2=CC=CC=C2)C(=O)C(CC3=CC=CC=C3)C(=O)<br />NO
InChI
1S/C25H26N2O3/c28-24(26-30)23(18-21-12-6-2-7-13-21)25(29)27(19-22-14-8-3-9-15-22)17-16-20-10-4-1-5-11-20/h1-15,23,30H,16-19H2,(H,26,28)
InChIKey
PQZSZTWFWIQBGX-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Aminopeptidase N Target Info Inhibitor [528703]
BioCyc Pathway Glutathione-mediated detoxification
KEGG Pathway Glutathione metabolism
Metabolic pathways
Renin-angiotensin system
Hematopoietic cell lineage
Pathway Interaction Database C-MYB transcription factor network
PathWhiz Pathway Glutathione Metabolism
Reactome Metabolism of Angiotensinogen to Angiotensins
WikiPathways Metabolism of Angiotensinogen to Angiotensins
Cardiac Progenitor Differentiation
miR-targeted genes in squamous cell - TarBase
miR-targeted genes in muscle cell - TarBase
miR-targeted genes in lymphocytes - TarBase
miR-targeted genes in leukocytes - TarBase
Glutathione metabolism
References
Ref 528703J Med Chem. 2007 Mar 22;50(6):1322-34. Epub 2007 Feb 28.Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.
Ref 528703J Med Chem. 2007 Mar 22;50(6):1322-34. Epub 2007 Feb 28.Novel selective inhibitors of the zinc plasmodial aminopeptidase PfA-M1 as potential antimalarial agents.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.